Arbutus Biopharma Corp. (ABUS)

4.675 +0.08 (+1.85%) USD  |  NASDAQ  |  Dec 11, 15:37
More

Arbutus Biopharma EV to Free Cash Flow

EV to Free Cash Flow Chart

View EV to Free Cash Flow for ABUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Free Cash Flow Range, Past 5 Years

View EV to Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Free Cash Flow Benchmarks

View EV to Free Cash Flow Benchmarks
Start Trial
Boston Scientific Corp. Upgrade
Trevi Therapeutics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. Upgrade
Theriva Biologics, Inc. Upgrade

EV to Free Cash Flow Related Metrics

EV to CFO Upgrade
EV to Revenues Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade